JANICZEK WEALTH MANAGEMENT, LLC - AMPIO PHARMACEUTICALS INC ownership

AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 129 filers reported holding AMPIO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANICZEK WEALTH MANAGEMENT, LLC ownership history of AMPIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$0
-100.0%
16,7190.0%0.00%
-100.0%
Q2 2022$3,000
-62.5%
16,7190.0%0.00%
-50.0%
Q1 2022$8,000
-20.0%
16,7190.0%0.00%
-33.3%
Q4 2021$10,000
-64.3%
16,7190.0%0.00%
-70.0%
Q3 2021$28,0000.0%16,7190.0%0.01%0.0%
Q2 2021$28,0000.0%16,7190.0%0.01%
-9.1%
Q1 2021$28,000
+3.7%
16,7190.0%0.01%
-15.4%
Q4 2020$27,000
+68.8%
16,7190.0%0.01%
+44.4%
Q3 2020$16,000
+45.5%
16,7190.0%0.01%
+50.0%
Q2 2020$11,000
+57.1%
16,7190.0%0.01%
+50.0%
Q1 2020$7,000
-30.0%
16,7190.0%0.00%0.0%
Q4 2019$10,000
+25.0%
16,7190.0%0.00%0.0%
Q3 2019$8,000
+33.3%
16,7190.0%0.00%
+33.3%
Q2 2019$6,000
-33.3%
16,7190.0%0.00%
-25.0%
Q1 2019$9,000
+28.6%
16,7190.0%0.00%0.0%
Q4 2018$7,000
-12.5%
16,7190.0%0.00%0.0%
Q3 2018$8,000
-78.4%
16,7190.0%0.00%
-80.0%
Q2 2018$37,000
-35.1%
16,7190.0%0.02%
-37.5%
Q1 2018$57,000
-16.2%
16,7190.0%0.03%
-13.5%
Q4 2017$68,000
+580.0%
16,7190.0%0.04%
+516.7%
Q3 2017$10,000
+11.1%
16,7190.0%0.01%
+20.0%
Q2 2017$9,000
-30.8%
16,7190.0%0.01%
-28.6%
Q1 2017$13,000
-13.3%
16,7190.0%0.01%0.0%
Q4 2016$15,00016,7190.01%
Other shareholders
AMPIO PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Cypress Capital Management LLC (WY) 234,225$132,0000.18%
Noven Financial Group, Inc. 123,772$70,0000.04%
Harvest Investment Services, LLC 109,443$60,0000.04%
GSA CAPITAL PARTNERS LLP 559,489$314,0000.03%
COURIER CAPITAL LLC 354,973$199,0000.03%
Valeo Financial Advisors, LLC 330,000$185,0000.02%
Transform Wealth, LLC 205,481$115,0000.02%
WEDBUSH SECURITIES INC 326,793$184,0000.02%
STEEL GROVE CAPITAL ADVISORS, LLC 55,500$31,0000.02%
MONTAG A & ASSOCIATES INC 230,000$129,0000.01%
View complete list of AMPIO PHARMACEUTICALS INC shareholders